Table 1: DEMOGRAPHICS OF STUDY PATIENTS, N (%) OR MEAN ± STANDARD DEVIATION.

Characteristic

Overall Sample

N = 373 (%)

Change in ED

Visits

Low ED Users    

High ED Users

p-value

Sex

 

 

 

 

< 0.0001

Female

230 (61.66)

-0.485

213 (92.61)

17(7.39)

 

Male

143 (38.34)

-0.293

103 (72.03)

40(27.97)

 

Age

 

 

 

 

0.133

18-40

149 (39.95)

-0.575

124 (83.22)

25 (16.78)

 

41-93

224 (60.05)

-0.385

172 (76.79)

52 (23.21)

 

Race

 

 

 

 

0.0236

Black

322 (86.33)

-0.527

253 (78.57)

69 (21.43)

 

WHITE

46 (12.33)

-0.347

40 (86.96)

6 (13.04)

 

Other

5 (1.34)

 

3 (60.00)

2 (40.00)

 

Smoking Status

 

 

 

 

0.056

Smoker

144 (38.6)

-0.125

107 (74.31)

37 (25.69)

 

Non-Smoker

229 (61.4)

-0.677

189 (82.53

40 (17.47)

 

Insurance Type

 

 

 

 

0.346

Free Care

142 (38.1)

 

118 (83.10)

24 (16.90)

 

Medicaid/Medicare

68 (18.2)

 

54 (79.41)

14 (20.59)

 

Private

130 (34.9)

 

101 (77.69)

29 (22.31)

 

Unknown

33 (8.8)

 

 

23 (69.70)

10 (30.30)

 

This table illustrates the characteristics of the 373 patients in the study. Low ED usage was defined as ≤ 1 asthma-related ED visits and High ED usage was defined as ≥ 2 asthma-related ED visits after receiving the written asthma action plan (WAAP). Change in ED visits represent the average decrease in ED visits one year before the WAAP to one year after.

*p-values for difference in ED use were calculated with Pearson chi-square test for categorical variables and paired samples t test for continuous variables.